Moors & Cabot’s Teva Pharmaceuticals TEVA Stock Holding History

Moors & Cabot’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,630	Closed	-$104K	–	898
2021 Q3	$104K	Sell	10,630 -1,835	-15%	-$18K	0.01%	797
2021 Q2	$123K	Sell	12,465 -3,615	-22%	-$35.7K	0.01%	764
2021 Q1	$188K	Sell	16,080 -13,485	-46%	-$158K	0.01%	694
2020 Q4	$289K	Sell	29,565 -5,970	-17%	-$58.4K	0.02%	540
2020 Q3	$320K	Sell	35,535 -7,175	-17%	-$64.6K	0.03%	454
2020 Q2	$524K	Buy	42,710 +4,105	+11%	+$50.4K	0.06%	305
2020 Q1	$343K	Sell	38,605 -4,650	-11%	-$41.3K	0.05%	334
2019 Q4	$429K	Buy	43,255 +20,873	+93%	+$207K	0.04%	377
2019 Q3	$152K	Buy	22,382 +4,445	+25%	+$30.2K	0.02%	564
2019 Q2	$165K	Sell	17,937 -1,963	-10%	-$18.1K	0.02%	521
2019 Q1	$316K	Sell	19,900 -7,800	-28%	-$124K	0.04%	374
2018 Q4	$434K	Sell	27,700 -21,102	-43%	-$331K	0.07%	282
2018 Q3	$1.06M	Buy	48,802 +16,025	+49%	+$346K	0.13%	184
2018 Q2	$788K	Buy	32,777 +15,870	+94%	+$382K	0.11%	214
2018 Q1	$289K	Buy	16,907 +1,655	+11%	+$28.3K	0.04%	439
2017 Q4	$294K	Sell	15,252 -7,353	-33%	-$142K	0.04%	423
2017 Q3	$404K	Sell	22,605 -2,181	-9%	-$39K	0.06%	348
2017 Q2	$823K	Sell	24,786 -1,343	-5%	-$44.6K	0.14%	191
2017 Q1	$833K	Buy	26,129 +222	+0.9%	+$7.08K	0.14%	188
2016 Q4	$943K	Buy	25,907 +6,146	+31%	+$224K	0.16%	157
2016 Q3	$917K	Buy	19,761 +1,226	+7%	+$56.9K	0.15%	160
2016 Q2	$935K	Buy	18,535 +1,013	+6%	+$51.1K	0.16%	153
2016 Q1	$939K	Sell	17,522 -6,167	-26%	-$330K	0.17%	155
2015 Q4	$1.56M	Sell	23,689 -1,054	-4%	-$69.3K	0.29%	95
2015 Q3	$1.4M	Sell	24,743 -5,542	-18%	-$312K	0.26%	102
2015 Q2	$1.8M	Sell	30,285 -589	-2%	-$35K	0.29%	86
2015 Q1	$1.92M	Buy	30,874 +736	+2%	+$45.8K	0.32%	85
2014 Q4	$1.74M	Sell	30,138 -841	-3%	-$48.5K	0.29%	88
2014 Q3	$1.66M	Sell	30,979 -2,301	-7%	-$124K	0.28%	91
2014 Q2	$1.74M	Buy	33,280 +13,161	+65%	+$689K	0.29%	84
2014 Q1	$1.06M	Buy	+20,119	New	+$1.06M	0.27%	100